CA2401295A1 - Procede de production de produits antiviraux issus d'extraits de plantes - Google Patents

Procede de production de produits antiviraux issus d'extraits de plantes Download PDF

Info

Publication number: CA2401295A1
Authority: CA; Canada
Prior art keywords: virus; compositions; hepatitis; hiv; chinese herbal
Prior art date: 1996-07-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

CA002401295A

Other languages

English (en)

Other versions

CA2401295C (fr

Inventor

Shie-Ming Hwang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SAGE R&D Inc

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-07-09

Filing date

1997-07-09

Publication date

1998-01-15

1997-07-09 Application filed by Individual filed Critical Individual

1997-07-09 Priority claimed from CA002271622A external-priority patent/CA2271622C/fr

1998-01-15 Publication of CA2401295A1 publication Critical patent/CA2401295A1/fr

2008-01-29 Application granted granted Critical

2008-01-29 Publication of CA2401295C publication Critical patent/CA2401295C/fr

2017-07-09 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

230000000840 anti-viral effect Effects 0.000 title abstract 2
229940121357 antivirals Drugs 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
229940126601 medicinal product Drugs 0.000 title 1
239000000419 plant extract Substances 0.000 title 1
241000725303 Human immunodeficiency virus Species 0.000 abstract 4
239000000203 mixture Substances 0.000 abstract 4
208000030507 AIDS Diseases 0.000 abstract 3
241000711549 Hepacivirus C Species 0.000 abstract 2
241000700721 Hepatitis B virus Species 0.000 abstract 2
241000700605 Viruses Species 0.000 abstract 2
241000411851 herbal medicine Species 0.000 abstract 2
208000005176 Hepatitis C Diseases 0.000 abstract 1
241000282412 Homo Species 0.000 abstract 1
241001465754 Metazoa Species 0.000 abstract 1
241000714177 Murine leukemia virus Species 0.000 abstract 1
239000000969 carrier Substances 0.000 abstract 1
239000000284 extract Substances 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Landscapes

Medicines Containing Plant Substances (AREA)

CA002401295A 1996-07-09 1997-07-09 Procede de production de produits antiviraux issus d'extraits de plantes Expired - Fee Related CA2401295C (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US1610096P	1996-07-09	1996-07-09
US60/016100		1996-07-09
US2146796P	1996-07-10	1996-07-10
US60/021467		1996-07-10
CA002271622A CA2271622C (fr)	1996-07-09	1997-07-09	Agents antiviraux issus d'extraits de plantes et utilisation de ces agents dans le traitement d'infections virales

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002271622A Division CA2271622C (fr)	1996-07-09	1997-07-09	Agents antiviraux issus d'extraits de plantes et utilisation de ces agents dans le traitement d'infections virales

Publications (2)

Publication Number	Publication Date
CA2401295A1 true CA2401295A1 (fr)	1998-01-15
CA2401295C CA2401295C (fr)	2008-01-29

Family

ID=27170967

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002401295A Expired - Fee Related CA2401295C (fr)	1996-07-09	1997-07-09	Procede de production de produits antiviraux issus d'extraits de plantes

Country Status (1)

Country	Link
CA (1)	CA2401295C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN115487106A (zh) *	2022-08-09	2022-12-20	北京康华远景科技股份有限公司	一种黄芩提取物的循环酸沉制备方法

1997
- 1997-07-09 CA CA002401295A patent/CA2401295C/fr not_active Expired - Fee Related

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN115487106A (zh) *	2022-08-09	2022-12-20	北京康华远景科技股份有限公司	一种黄芩提取物的循环酸沉制备方法

Also Published As

Publication number	Publication date
CA2401295C (fr)	2008-01-29

Similar Documents

Publication	Publication Date	Title
CA2271622A1 (fr)	1998-01-15	Agents antiviraux issus d'extraits de plantes et utilisation de ces agents dans le traitement d'infections virales
WO2003063771A3 (fr)	2005-07-07	Nucleosides n4-acylcytosines pour le traitement d'infections virales
WO2001010456A3 (fr)	2001-09-20	Peptides bloquant les infections virales et procedes d'utilisation correspondants
CA2165821A1 (fr)	1995-01-05	Oligonucleotides antisens et utilisation therapeutique de ceux-ci dans l'infection par le virus de l'immunodeficience humaine
AU644095B2 (en)	1993-12-02	Antiviral compounds
DK92788A (da)	1988-02-23	Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira
WO2001078648A3 (fr)	2003-12-18	Derives de 6-methylnicotinamide utilises comme agents antiviraux
CA2198010A1 (fr)	1996-03-07	Succinate de 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2- cyclopentene-1-methanol, agent antiviral
IE882585L (en)	1990-02-25	Viral treatment system
AU2880595A (en)	1996-01-25	Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
CA2155020A1 (fr)	1994-08-04	Composes antiviraux a base de naphtoquinone; compositions a base de ces produits et utilisations
AP9300513A0 (en)	1993-04-30	Compositions for the treatment of infection and disease caused by hepatitis b virus(hbv)
WO1998001144A2 (fr)	1998-01-15	Agents antiviraux issus d"extraits de plantes et utilisation de ces agents dans le traitement d"infections virales
DK720588D0 (da)	1988-12-23	Forbindelser til anvendelse ved behandling eller forebyggelse af human-immundefektvirus-(hiv)-infektion, og farmaceutiske praeparater indeholdende samme
MY157594A (en)	2016-06-20	Compositions of matter useful in the treatment of viral infections derived from plant extracts
WO1996001110A3 (fr)	1996-02-22	Triple combinaison anti-vih
EP0316592A3 (fr)	1990-09-19	3'-Fluoro-2',3'-didéoxyuridine, et ses application thérapeutique
EP0963441A4 (fr)	2002-10-02	Therapie de l'infection a virus de l'immunodeficience humaine (vih) par inactivation de co-recepteurs du vih
DE69922642D1 (de)	2005-01-20	Virale chimären aus caev und hiv-1 genetischen elementen
EP0362755A3 (fr)	1990-08-22	Clone de cellules-t cytotoxiques humaines et anticorps contre ce clone
Cottone et al.	1989	Hepatitis, HIV infection and AIDS: some issues for the practitioner
AU3593095A (en)	1996-04-09	Method of treatment of human immunodeficiency virus (hiv) infection
WO2001030325A3 (fr)	2002-01-24	Utilisation d'un inhibiteur de la phosphotyrosylphosphatase dans le traitement de patients immunodeprimes
GR3032621T3 (en)	2000-05-31	Extracts of piliostigma thonningii, the use thereof and formulations containing them.
CA2088788A1 (fr)	1992-02-23	Peptides entravant les infections par le virus de l'immunodeficience humaine et methodes d'utilisation correspondantes

Legal Events

Date	Code	Title	Description
2003-03-26	EEER	Examination request
2010-07-09	MKLA	Lapsed